Alnylam Pharmaceuticals Inc
About
Alnylam Pharmaceuticals Inc (NASDAQ:ALNY) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 16 2026
Alnylam to Webcast Conference Call Discussing First Quarter 2026 Financial Results
Mar 30 2026
New Data Presented at ACC.26 Further Support Benefits of Vutrisiran in ATTR-CM and Potential of Zilebesiran for Hypertension Management
Mar 24 2026
Viz.ai Partners with Alnylam Pharmaceuticals to Advance Earlier Identification and Care Coordination in Cardiac Amyloidosis
Mar 24 2026
Alnylam Advances Future of ATTR-CM Care Through Strategic Collaboration with Viz.ai and Support for the American Heart Association
Mar 10 2026
Alnylam to Webcast TTR Investor Webinar
Financials
Revenue
$3.71 B
Market Cap
$42.29 B
P/E Ratio
136.85
EPS
2.33